{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:32:58Z","timestamp":1779409978587,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guizhou Provincial Basic Research Program","award":["ZK[2022] General 494"],"award-info":[{"award-number":["ZK[2022] General 494"]}]},{"name":"Guizhou Province Science and Technology Program Project","award":["ZSYS [2025] 040"],"award-info":[{"award-number":["ZSYS [2025] 040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gout is a prevalent, chronic inflammatory joint diseases, and its global prevalence and incidence are continue to rise. Currently, the adverse side effects of anti-gout drugs underscore the urgent need for safer and more effective anti-gout agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cichoriin is a kind of coumarin, which exhibits diversity of biological activities. The current investigation aimed to explore the mechanism of the inhibition of MSU-induced gouty inflammation by cichoriin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The enzyme inhibitory assay of P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R, cell viability detection, ELISA, immunofluorescence staining, and flow cytometry were used to explore the molecular mechanism of cichoriin in the inhibition of MSU-induced gouty inflammation. The molecular level details of inhibitory effects of chchoriin against P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R were obtained by molecular dynamics simulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The in vitro experiments revealed that cichoriin could inhibit the activity of P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R, up-regulate the expressions of NLRP3, Caspase\u22121, GSDMD and ASC, increase IL\u22121\u03b2 and IL\u221218 levels, and decrease the percentage of Caspase\u22121\/PI double-positive cells. The computational calculations revealed that cichoriin and P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R could form a stable and rigid complex. Free energy landscape exhibited that cichoriin stabilized the global conformations of P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R to the minimum global energy. MM-PBSA provided evidence for cichoriin\u2019s stability inside the binding pocket of P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R with a binding free energy of -35.13\u00a0kcal\/mol. The decomposition of binding energy showed the pivotal amino acids residues responsible for the stability of cichoriin\u2019s interaction with P2Y\n                      <jats:sub>14<\/jats:sub>\n                      R by forming hydrogen bonds and hydrophobic interactions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work highlighted the potential roles of cichoriin in attenuating MSU-induced gouty inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12896-026-01151-z","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:46:29Z","timestamp":1776253589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into how cichoriin inhibits P2Y14R to suppress MSU-induced gouty inflammation"],"prefix":"10.1186","volume":"26","author":[{"given":"Xue","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"1","key":"1151_CR1","first-page":"27","volume":"58","author":"T Pascart","year":"2019","unstructured":"Pascart T, Liot\u00e9 F. Gout: state of the art after a decade of developments. Rheumatology (Oxford). 2019;58(1):27\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1151_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/acr.24475","volume":"74","author":"A Garcia-Guillen","year":"2022","unstructured":"Garcia-Guillen A, Stewart S, Su I, Taylor WJ, Gaffo AL, Gott M, et al. Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study. Arthritis Care Res (Hoboken). 2022;74(2):317\u201323.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1151_CR3","doi-asserted-by":"publisher","first-page":"e45943","DOI":"10.2196\/45943","volume":"9","author":"Q He","year":"2023","unstructured":"He Q, Mok TN, Sin TH, Yin J, Li S, Yin Y, et al. Global, Regional, and National Prevalence of Gout From 1990 to 2019: Age-Period-Cohort Analysis With Future Burden Prediction. JMIR Public Health Surveill. 2023;9:e45943.","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"1151_CR4","doi-asserted-by":"publisher","first-page":"e13937","DOI":"10.1111\/eci.13937","volume":"53","author":"YJ Jeong","year":"2023","unstructured":"Jeong YJ, Park S, Yon DK, Lee SW, Tizaoui K, Koyanagi A, et al. Global burden of gout in 1990\u20132019: A systematic analysis of the Global Burden of Disease study 2019. Eur J Clin Invest. 2023;53(4):e13937.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"1151_CR5","first-page":"e58873","volume":"16","author":"JA Alshahrani","year":"2024","unstructured":"Alshahrani JA, Saleh Alzahrani SA, Ali AlGhamdi OS, Ali Alzahrani NG, Ahmed Alzahrani FA, Alshehri FS, et al. Gouty Arthritis Across Ages: Understanding Disease Patterns and Predictors. Cureus. 2024;16(4):e58873.","journal-title":"Cureus"},{"issue":"1","key":"1151_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/bbb\/zbac173","volume":"87","author":"Y Shindo","year":"2022","unstructured":"Shindo Y, Taniguchi A, Masuda A, Masuda T. Identification of the roasting reaction products of ferulic and sinapic acids and their xanthine oxidase inhibitory activity. Biosci Biotechnol Biochem. 2022;87(1):114\u20138.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"1151_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2017-212046","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Nicolaou S, Baumgartner S, Hu J, Fung M, Choi HK. Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol. Ann Rheum Dis. 2018;77(3):364\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1151_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.0105-2896.2009.00860.x","volume":"233","author":"F Martinon","year":"2010","unstructured":"Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev. 2010;233(1):218\u201332.","journal-title":"Immunol Rev"},{"issue":"11","key":"1151_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639\u201347.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1151_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148\u201359.","journal-title":"Cell Mol Immunol"},{"key":"1151_CR11","first-page":"39","volume":"4","author":"SR Kingsbury","year":"2011","unstructured":"Kingsbury SR, Conaghan PG, McDermott MF. The role of the NLRP3 inflammasome in gout. J Inflamm Res. 2011;4:39\u201349.","journal-title":"J Inflamm Res"},{"key":"1151_CR12","doi-asserted-by":"publisher","first-page":"580593","DOI":"10.3389\/fimmu.2020.580593","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin Y, Luo T, Weng A, Huang X, Yao Y, Fu Z, et al. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling. Front Immunol. 2020;11:580593.","journal-title":"Front Immunol"},{"issue":"4","key":"1151_CR13","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1002\/jcp.27204","volume":"234","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Li LH, Rao YK, Ju TC, Nai YS, Chen YW, et al. Mechanistic insight into the attenuation of gouty inflammation by Taiwanese green propolis via inhibition of the NLRP3 inflammasome. J Cell Physiol. 2019;234(4):4081\u201394.","journal-title":"J Cell Physiol"},{"issue":"7329","key":"1151_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135.","journal-title":"Nature"},{"key":"1151_CR15","doi-asserted-by":"crossref","unstructured":"Semenova IB. Role of purinergic receptors in immune response. Zh Mikrobiol Epidemiol Immunobiol. 2016;(2):107\u201319.","DOI":"10.36233\/0372-9311-2016-2-107-119"},{"key":"1151_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neuropharm.2015.10.008","volume":"104","author":"\u00c1 Oliveira","year":"2016","unstructured":"Oliveira \u00c1, Illes P, Ulrich H. Purinergic receptors in embryonic and adult neurogenesis. Neuropharmacology. 2016;104:272\u201381.","journal-title":"Neuropharmacology"},{"issue":"4","key":"1151_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11302-016-9524-5","volume":"12","author":"JI Sesma","year":"2016","unstructured":"Sesma JI, Weitzer CD, Livraghi-Butrico A, Dang H, Donaldson S, Alexis NE, et al. UDP-glucose promotes neutrophil recruitment in the lung. Purinergic Signal. 2016;12(4):627\u201335.","journal-title":"Purinergic Signal"},{"issue":"6","key":"1151_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jid.2016.01.026","volume":"136","author":"H Uratsuji","year":"2016","unstructured":"Uratsuji H, Tada Y, Hau CS, Shibata S, Kamata M, Kawashima T, et al. Monosodium Urate Crystals Induce Functional Expression of P2Y14 Receptor in Human Keratinocytes. J Invest Dermatol. 2016;136(6):1293\u20136.","journal-title":"J Invest Dermatol"},{"key":"1151_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.intimp.2019.01.021","volume":"71","author":"Y Chen","year":"2019","unstructured":"Chen Y, Le TH, Du Q, Zhao Z, Liu Y, Zou J, et al. Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling. Int Immunopharmacol. 2019;71:144\u201354.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1151_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41419-020-2609-7","volume":"11","author":"H Li","year":"2020","unstructured":"Li H, Jiang W, Ye S, Zhou M, Liu C, Yang X, et al. P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages. Cell Death Dis. 2020;11(5):394.","journal-title":"Cell Death Dis"},{"key":"1151_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jare.2020.02.007","volume":"23","author":"W Wang","year":"2020","unstructured":"Wang W, Liu C, Li H, Tian S, Liu Y, Wang N, et al. Discovery of novel and potent P2Y14R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis. J Adv Res. 2020;23:133\u201342.","journal-title":"J Adv Res"},{"issue":"30","key":"1151_CR22","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2174\/1381612043382710","volume":"10","author":"KC Fylaktakidou","year":"2004","unstructured":"Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory\/ antioxidant activities. Curr Pharm Des. 2004;10(30):3813\u201333.","journal-title":"Curr Pharm Des"},{"key":"1151_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11696-023-03105-7","volume":"78","author":"YF Mustafa","year":"2024","unstructured":"Mustafa YF. Coumarins from carcinogenic phenol: synthesis, characterization, in silico, biosafety, anticancer, antioxidant, and anti-inflammatory assessments. Chem Pap. 2024;78:493\u2013504.","journal-title":"Chem Pap"},{"issue":"9","key":"1151_CR24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1753-4887.2012.00509.x","volume":"70","author":"M Gonz\u00e1lez-Castej\u00f3n","year":"2012","unstructured":"Gonz\u00e1lez-Castej\u00f3n M, Visioli F, Rodriguez-Casado A. Diverse biological activities of dandelion. Nutr Rev. 2012;70(9):534\u201347.","journal-title":"Nutr Rev"},{"issue":"8","key":"1151_CR25","first-page":"509","volume":"7","author":"HE Khalil","year":"2015","unstructured":"Khalil HE, Kamel MS. Phytochemical and biological studies of Cichorium endivia L. leaves. J Pharm Sci Res. 2015;7(8):509.","journal-title":"J Pharm Sci Res"},{"issue":"3","key":"1151_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/molecules14030939","volume":"14","author":"A Basile","year":"2009","unstructured":"Basile A, Sorbo S, Spadaro V, Bruno M, Maggio A, Faraone N, et al. Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (Apiaceae). Molecules. 2009;14(3):939\u201352.","journal-title":"Molecules"},{"issue":"11","key":"1151_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/13543776.2017.1360284","volume":"27","author":"A Detsi","year":"2017","unstructured":"Detsi A, Kontogiorgis C, Hadjipavlou-Litina D. Coumarin derivatives: an updated patent review (2015\u20132016). Expert Opin Ther Pat. 2017;27(11):1201\u201326.","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"1151_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.31083\/ph.2014.3642","volume":"69","author":"X Ling","year":"2014","unstructured":"Ling X, Bochu W. A review of phytotherapy of gout: perspective of new pharmacological treatments. Pharmazie. 2014;69(4):243\u201356.","journal-title":"Pharmazie"},{"issue":"1","key":"1151_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","volume":"20","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Koenders MI, Azam T, Tengesdal IW, Powers N, et al. NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis. Arthritis Res Ther. 2018;20(1):169.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1151_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677\u201387.","journal-title":"Nat Med"},{"issue":"7381","key":"1151_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481(7381):278\u201386.","journal-title":"Nature"},{"issue":"1","key":"1151_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/jm901432g","volume":"53","author":"A Das","year":"2010","unstructured":"Das A, Ko H, Burianek LE, Barrett MO, Harden TK, Jacobson KA. Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5\u2019-diphosphoglucose and its replacement with alkyl and aryl groups. J Med Chem. 2010;53(1):471\u201380.","journal-title":"J Med Chem"},{"issue":"10","key":"1151_CR33","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.bmcl.2011.03.081","volume":"21","author":"JY Gauthier","year":"2011","unstructured":"Gauthier JY, Belley M, Desch\u00eanes D, Fournier JF, Gagn\u00e9 S, Gareau Y, et al. The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14. Bioorg Med Chem Lett. 2011;21(10):2836\u20139.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"1151_CR34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1124\/mol.109.058578","volume":"76","author":"RL Carter","year":"2009","unstructured":"Carter RL, Fricks IP, Barrett MO, Burianek LE, Zhou Y, Ko H, et al. Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor. Mol Pharmacol. 2009;76(6):1341\u20138.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1151_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1124\/jpet.109.150730","volume":"330","author":"IP Fricks","year":"2009","unstructured":"Fricks IP, Carter RL, Lazarowski ER, Harden TK. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems. J Pharmacol Exp Ther. 2009;330(1):162\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"19","key":"1151_CR36","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.3390\/ijms251910853","volume":"25","author":"TK Yao","year":"2024","unstructured":"Yao TK, Lee RP, Wu WT, Chen IH, Yu TC, Yeh KT. Advances in Gouty Arthritis Management: Integration of Established Therapies, Emerging Treatments, and Lifestyle Interventions. Int J Mol Sci. 2024;25(19):10853.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1151_CR37","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s00044-012-0321-6","volume":"22","author":"Y Bansal","year":"2012","unstructured":"Bansal Y, Sethi P, Bansal G. Coumarin: a potential nucleus for anti-inflammatory molecules. Med Chem Res. 2012;22(7):3049\u201360.","journal-title":"Med Chem Res"},{"issue":"3","key":"1151_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1042\/bj3290477","volume":"329","author":"R CURTO","year":"1998","unstructured":"CURTO R, VOIT OE. Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man. Biochem J. 1998;329(3):477\u201387.","journal-title":"Biochem J"},{"issue":"4","key":"1151_CR39","first-page":"475","volume":"10","author":"M Luo","year":"2005","unstructured":"Luo M, Liu F, Zou J, Yu J, Huang L, Ye L, et al. Explorative clinical trial on effect of relieving pain in treatment of patients with primary acute gouty arthritis by cortex fraxini total coumarin. Chin J Clin Pharmacol Ther. 2005;10(4):475.","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"1151_CR40","doi-asserted-by":"publisher","first-page":"103330","DOI":"10.1016\/j.bioorg.2019.103330","volume":"93","author":"\u00d6 Bahad\u0131r Ac\u0131kara","year":"2019","unstructured":"Bahad\u0131r Ac\u0131kara \u00d6, Ilhan M, Kurtul E, \u0160mejkal K, K\u00fcpeli Akkol E. Inhibitory activity of Podospermum canum and its active components on collagenase, elastase and hyaluronidase enzymes. Bioorg Chem. 2019;93:103330.","journal-title":"Bioorg Chem"},{"issue":"4","key":"1151_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/15368378.2012.662193","volume":"31","author":"MA Al-Akhras","year":"2012","unstructured":"Al-Akhras MA, Aljarrah K, Al-Khateeb H, Jaradat A, Al-Omari A, Al-Nasser A, et al. Introducing Cichorium Pumilum as a potential therapeutical agent against drug-induced benign breast tumor in rats. Electromagn Biol Med. 2012;31(4):299\u2013309.","journal-title":"Electromagn Biol Med"},{"issue":"1","key":"1151_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/biom10010074","volume":"10","author":"CN Zhao","year":"2020","unstructured":"Zhao CN, Yao ZL, Yang D, Ke J, Wu QL, Li JK, et al. Chemical Constituents from Fraxinus hupehensis and Their Antifungal and Herbicidal Activities. Biomolecules. 2020;10(1):74.","journal-title":"Biomolecules"},{"issue":"4","key":"1151_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00299-005-0953-9","volume":"24","author":"J Malarz","year":"2005","unstructured":"Malarz J, Stojakowska A, Szneler E, Kisiel W. Furofuran lignans from a callus culture of Cichorium intybus. Plant Cell Rep. 2005;24(4):246\u20139.","journal-title":"Plant Cell Rep"},{"key":"1151_CR44","doi-asserted-by":"crossref","unstructured":"Alfaro-Jim\u00e9nez M\u00c1, Zugasti-Cruz A, Silva-Belmares SY, Ascacio-Vald\u00e9s JA, Sierra-Rivera CA, Anti-inflammatory. antioxidant, and antitumoral potential of plants of the asteraceae family. In Functional Foods and Nutraceuticals for Human Health. Apple Academic. 2021;331\u2009\u2013\u200980.","DOI":"10.1201\/9781003097358-13"},{"issue":"6","key":"1151_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/joca.2002.0526","volume":"10","author":"JH Choi","year":"2002","unstructured":"Choi JH, Choi JH, Kim DY, Yoon JH, Youn HY, Yi JB, et al. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage. 2002;10(6):471\u20138.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"1151_CR46","doi-asserted-by":"publisher","first-page":"e202402879","DOI":"10.1002\/cbdv.202402879","volume":"22","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, He W, Yang Y, Liu R, Wang X, Bai J. Phytochemical Constituents and Pharmacological Properties of Fraxinus spp. Rev Chem Biodivers. 2025;22(7):e202402879.","journal-title":"Rev Chem Biodivers"},{"issue":"2","key":"1151_CR47","first-page":"33","volume":"11","author":"T Riaz","year":"2024","unstructured":"Riaz T, Akram M, Laila U, Khalil T, Zainab R, Iftikhar M, et al. Phytochemistry and pharmacology of Cichorium intybus. Int Arch Integr Med. 2024;11(2):33\u201346.","journal-title":"Int Arch Integr Med"},{"issue":"6","key":"1151_CR48","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/1040841X.2020.1828816","volume":"46","author":"R Ayswaria","year":"2020","unstructured":"Ayswaria R, Vasu V, Krishna R. Diverse endophytic Streptomyces species with dynamic metabolites and their meritorious applications: a critical review. Crit Rev Microbiol. 2020;46(6):750\u20138.","journal-title":"Crit Rev Microbiol"},{"issue":"11","key":"1151_CR49","first-page":"1731","volume":"12","author":"HE Khalil","year":"2022","unstructured":"Khalil HE, Abdelwahab MF, Ibrahim HM, AlYahya KA, Altaweel AA, Alasoom AJ, et al. Cichoriin, a Biocoumarin, Mitigates Oxidative Stress and Associated Adverse Dysfunctions on High-Fat Diet-Induced Obesity in Rats. Life (Basel). 2022;12(11):1731.","journal-title":"Life (Basel)"},{"key":"1151_CR50","doi-asserted-by":"publisher","first-page":"109507","DOI":"10.1016\/j.intimp.2022.109507","volume":"114","author":"M Zhou","year":"2023","unstructured":"Zhou M, Liu C, Guo Y, Qian J, Wang Y, Zhang Z, et al. HQL6 serves as a novel P2Y14 receptor antagonist to ameliorate acute gouty arthritis through inhibiting macrophage pyroptosis. Int Immunopharmacol. 2023;114:109507.","journal-title":"Int Immunopharmacol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01151-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01151-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01151-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:02:39Z","timestamp":1779408159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01151-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01151-z","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}